Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety, pharmacokinetics, and clinical effects of IV PT-112 in advanced solid tumors with dose expansion cohorts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Solid Tumors

Drugs mentioned

• PT-112

Snippet

Sponsor: Promontory Therapeutics Inc. | Conditions: Advanced Solid Tumors, CRPC | Phase 2 | Status: ACTIVE_NOT_RECRUITING